X0306 4 2013-04-25 1 0001375247 Obagi Medical Products, Inc. OMPI 0001359475 Romm Preston S 3760 KILROY AIRPORT WAY SUITE 500 LONG BEACH CA 90806 0 1 0 0 CFO and Exec. VP Stock option (right to buy) 10.00 2013-04-25 4 D 0 71195 14.00 D 2018-07-01 Common stock 71195 0 D Stock option (right to buy) 11.49 2013-04-25 4 D 0 50000 12.51 D 2020-03-08 Common Stock 50000 0 D Stock option (right to buy) 9.71 2013-04-25 4 D 0 50000 14.29 D 2021-11-29 Common Stock 50000 0 D Stock option (right to buy) 12.70 2013-04-25 4 D 0 50000 11.30 D 2022-05-01 Common Stock 50000 0 D This stock option immediately vested in full and was converted into the right to receive cash in an amount equal to the product of (A) the total number of shares subject to the option, and (B) the difference between $24.00 minus the exercise price per share of the option, pursuant to the terms of the Agreement and Plan of Merger, dated as of March 19, 2013, among the issuer, Odysseus Acquisition Corp., Valeant Pharmaceuticals International and Valeant Pharmaceuticals International, Inc., as amended, and the issuer's 2005 Stock Incentive Plan, as amended, and as approved by the issuer's Compensation Committee. Preston S. Romm 2013-04-26